• PEAK Matrix®
    July 16, 2025

    In recent years, life sciences enterprises have reprioritized and overhauled their R&D investments. They now focus on streamlining their pipelines and shifting toward new and large molecules. This transformation has compelled aggressive cost containment initiatives, prompting…
  • Provider Compendium
    Sep. 30, 2025

    In recent years, life sciences enterprises have reoriented their R&D investments, prioritizing pipeline efficiency and a strategic focus on large and novel molecules. This shift has intensified efforts around cost containment and created a stronger need…
  • Tech Provider Spotlight
    Aug. 17, 2026

    Prior authorization for healthcare payers is shifting from manual, fax-heavy, and fragmented workflows toward more integrated, interoperable, and technology-enabled operating models. Payers are under growing pressure to reduce administrative burden, improve turnaround times, manage increasing authorization…